42Stockpicking

VCEL

Vericel Corp
NASDAQ·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
EV/EBITDAi
P/Bi
5,0
65th %ile · 404p
P/Si
4,2
53rd %ile · 356p
EV/Salesi
4,0
51st %ile · 356p
Div yieldi

Kursudvikling

Kun 82 handelsdage i databasen. Viser al tilgængelig historik.

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 10.6.2026none
Prishistorik
0,3 år
Pris-dage
63
Årsregnskaber
18
Peers
0/0
Valuation
3/6
Fundamentals
8/8
Datovindue
2026-02-17 til 2026-05-18

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Mangler ca. 9,8 års prishistorik før ideal/full.
  • Backfill mindst 1 års daglige priser før seriøs teknisk vurdering.
  • Kør compute-multiples for manglende valuation metrics.

Seneste assessment

VCEL vurderet 2026-06-10

Score
51.1%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

58%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

63%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

55%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

54%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

46%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

65%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

62%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: P/E relative valuation needs both own multiple and peer median.

Insider activity

Net 90d (aktier)
-29.375
Net 90d (værdi)
-1.158.675 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
18.6.2026Flynn Sean C.Chief Legal Officer◆ OPT.15.000243.750 USDsec
18.6.2026Flynn Sean C.Chief Legal Officer▼ SALG-15.000-603.150 USDsec
18.6.2026Halpin MichaelChief Operating Officer◆ OPT.10.000166.600 USDsec
18.6.2026Halpin MichaelChief Operating Officer▼ SALG-10.000-402.400 USDsec
2.6.2026Hopper Jonathan MarkChief Medical Officer◆ OPT.4.37572.888 USDsec
2.6.2026Hopper Jonathan MarkChief Medical Officer▼ SALG-4.375-153.125 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q130.4.2026-0,12-0,16+23.4%+23.4%Beat
2025Q430.1.20260,450,38+17.8%+17.8%Beat
2025Q330.10.20250,10-0,01+850.2%+850.2%Beat
2025Q230.7.2025-0,01-0,04+72.7%+72.7%Beat